This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier Wins Five First Prizes At BMA Medical Book Awards Competition

PHILADELPHIA, Pennsylvania, September 26, 2013 /PRNewswire/ --

Elsevier congratulates its award-winning medical authors and editors for consistently producing high-quality medical content

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 25 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on September 17, 2013. This year publishers submitted more than 640 products, and the BMA awarded 122 prizes, with 21 first prizes and 101 highly commended prizes.

"We congratulate all of the winners and especially thank all of the authors, editors and Elsevier publishing staff who have worked on these prize-winning titles," said Linda Belfus, Senior Vice President at Elsevier. "This is an amazing achievement and reflects our dedication to developing and delivering quality content."

Elsevier received First prizes in the following categories:

"We are really delighted to receive this award on behalf of our authors, our Elsevier editorial team and our digital partners at Inkling," said Parveen Kumar, CBE, BSc, MD, DM (HC), FRCP, FRCP (Edin), co-author of Kumar & Clark ' s Clinical Medicine. "The whole team worked very hard to create an engaging, multimedia interface to the demanding content of this book in order to accommodate all learning styles and improve the student experience. We all very much appreciate this wonderful endorsement from the BMA."

Dr. Kumar attended the ceremony, as did Anthony du Vivier, MD, FRCP, author of Atlas of Clinical Dermatology.

"I'm absolutely delighted with the BMA tribute and was helped by a brilliant team at Elsevier to pull it all together," said Dr. du Vivier. "Many thanks to my editors Russell Gabbedy and Sharon Nash."

Elsevier also received Highly Commended prizes in the following categories:

For more information about the awards, please visit the BMA website.

# # #

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs